BeStock  

COMPASS Pathways CMPS

US equityMarket cap rank #3068Medical Care Facilities
$8.05 −$0.60 (-6.94%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.20 +1.86%
Open$8.45
Prev close$8.65
Day range$7.82 – $8.45
Volume6.09M
Market cap$1.14B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership76.2%+3.40 pts vs. prior quarter
Institutions holding259+18 vs. prior quarter
Insider trades (recent)33 buys / 17 sellsNet buying
ARK fund activity+600,709 sh1 recent transactions · last 2 Nov 2026
Short interest12.42% of floatDays to cover 7.7 · as of 30 Oct 2026
Short-sale volume share17.1%5-day average of daily volume

Short-sale volume as % of daily volume

6%12%18%25%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$4.73M (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

−$5.1MSuper+$374.7KBig+$2.9MMid−$869.1KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 28.9% of shares outstanding.

Largest holders

  • Deep Track Capital, LP8.58%
  • RTW Investments, LP7.55%
  • BIT Capital GmbH5.75%
  • Tang Capital Management, LLC3.53%
  • ARK Investment Management LLC3.46%
  • Eli Lilly and Company3.36%
  • Two Sigma Investments, LP3.15%
  • Marshall Wace LLP3.05%

By investor type

  • Hedge Fund30.51%
  • Mutual Fund24.83%
  • VC/PE Fund11.59%
  • Public Company7.09%
  • Private Company1.74%
  • Individual/Insider1.60%
  • Endowment Fund0.25%
  • Family Office/Trust0.20%

Reported short interest has risen from 10.18% to 12.42% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +457,138 0.3%
BIT Capital GmbH Mutual Fund 2026/Q3 +1,799,483 5.7%
UBS Asset Management Mutual Fund 2026/Q3 +1,636,784 2.2%
ARK Investment Management LLC Mutual Fund 2026/Q3 +1,453,648 3.5%
Patient Square Capital, LP VC/PE Fund 2026/Q3 +1,056,269 0.7%
Creek Drive Management Group LLC Hedge Fund 2026/Q3 +756,000 0.9%
Centerbook Partners LP Hedge Fund 2026/Q3 +570,349 0.5%
Morgan Stanley Public Company 2026/Q3 +533,761 0.8%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +533,761 0.8%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +321,106 0.2%
Aisling Capital Management LP VC/PE Fund 2026/Q3 +300,000 1.2%
BIT Capital GmbH Mutual Fund 2026/Q3 +2,857,563 4.6%
Point72 Asset Management, L.P. Hedge Fund 2026/Q3 +2,620,878 1.8%
Logos Global Management, L.P. Hedge Fund 2026/Q3 +2,250,000 1.6%
Bank of America Corporation Public Company 2026/Q3 +1,987,016 1.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Aug 2026 Annalisa Lisa Jenkins Former Independent Non-Executive Director Intent to Sell (Form 144) -26,000 $13.30 –
6 Aug 2026 Annalisa Lisa Jenkins Former Independent Non-Executive Director Intent to Sell (Form 144) -83,771 $13.72 –
2 Aug 2026 Kabir Nath Chief Executive Officer Sale to Issuer -5,962 $11.25 64,728
26 May 2026 Jeffrey Jonas Independent Director Other Derivative Acquisition +21,110 $11.85 21,110
26 May 2026 Justin Gover Independent Director Other Derivative Acquisition +21,110 $11.85 21,110
26 May 2026 Gino Santini Independent Chairperson Other Derivative Acquisition +30,158 $11.85 30,158
26 May 2026 David Norton Independent Director Other Derivative Acquisition +21,110 $11.85 21,110
26 May 2026 Daphne Karydas Independent Director Other Derivative Acquisition +21,110 $11.85 21,110
26 May 2026 Robert McQuade Independent Non-Executive Director Other Derivative Acquisition +21,110 $11.85 21,110
26 May 2026 Wayne Riley Independent Non-Executive Director Other Derivative Acquisition +21,110 $11.85 21,110
26 May 2026 Kathleen Tregoning Independent Director Other Derivative Acquisition +41,119 $11.85 41,119
25 Mar 2026 Teri Loxam Chief Financial Officer Other Acquisition +75,000 – 125,109
25 Mar 2026 Teri Loxam Chief Financial Officer Other Derivative Acquisition +157,635 $5.64 157,635
25 Mar 2026 Kabir Nath Chief Executive Officer Other Acquisition +175,000 – 301,508
25 Mar 2026 Kabir Nath Chief Executive Officer Other Derivative Acquisition +367,815 $5.64 367,815
25 Mar 2026 Guy Goodwin Chief Medical Officer Other Derivative Acquisition +170,600 $5.64 115,600
10 Mar 2026 Teri Loxam Chief Financial Officer Sale to Issuer -1,781 $6.89 26,893
10 Mar 2026 Kabir Nath Chief Executive Officer Sale to Issuer -13,131 $6.89 65,482
1 Mar 2026 Teri Loxam Chief Financial Officer Sale to Issuer -4,467 $7.02 22,424
1 Feb 2026 Kabir Nath Chief Executive Officer Sale to Issuer -16,181 $6.61 54,571

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 17,201,909 12.4% 7.7
15 Oct 2026 17,670,961 12.8% 6.8
30 Sep 2026 17,034,415 12.3% 5.9
15 Sep 2026 15,235,260 11.0% 5.6
31 Aug 2026 14,469,018 10.4% 6.5
14 Aug 2026 14,099,681 10.2% 4.5

Discussion

No comments yet — be the first to weigh in on CMPS.

Sign in to join the discussion.

Scroll to Top